FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201609182> ?p ?o ?g. }

• W3201609182 endingPage "142" @default.
• W3201609182 startingPage "135" @default.
• W3201609182 abstract "Pleural effusion (PE) has been one of the promising sources of liquid biopsy in advanced lung cancer patients. However, its clinical utility is not widely accepted due to the lack of full estimation of its potential versus routine clinical samples.A total of 164 advanced lung cancer patients were enrolled with 164 matched tumor tissue and PE-cfDNA, 153 accompanied plasma and 63 1PE-sDNA.PE-cfDNA displayed significantly higher median mutant allele frequency and an overall mutation concordance rate of 65% to tissue, which was higher than PE-sDNA (43%) and plasma-cfDNA (43%). The discrepancies between PE-cfDNA and tumor tissue were high in several genes, including SMARCA4, PIK3CA, ERBB2, KM T2A, ALK and NF1. For clinically actionable mutations, the concordance rate between PE-cfDNA and tumor tissue is 87%. Eleven patients were identified with actionable mutations in PE-cfDNA and four patients benefited from PE-cfDNA-guided targeted. Meanwhile, PE-cfDNA recapitulated mutations of diverse tissue origins and provided more mutational information under the circumstance that tumor tissue or tumor tissue of different origins were unavailable. The combination of tumor tissue and PE-cfDNA profiling increased positive detection rates of patients compared to tumor tissue alone. Our finding highlighted the importance of PE-cfDNA in the optimal selection of patients for targeted therapy.The PE-cfDNA-based liquid biopsy displays better performance in the characterization of gene alterations than PE-sDNA and plasma-cfDNA. PE-cfDNA together with tumor tissue profiling optimizes comprehensively genomic profiling of lung cancer patients, which might be important for selecting patients for better treatment management." @default.
• W3201609182 created "2021-09-27" @default.
• W3201609182 creator A5004501438 @default.
• W3201609182 creator A5013978940 @default.
• W3201609182 creator A5016050402 @default.
• W3201609182 creator A5020104705 @default.
• W3201609182 creator A5022092259 @default.
• W3201609182 creator A5032428632 @default.
• W3201609182 creator A5034124730 @default.
• W3201609182 creator A5043568223 @default.
• W3201609182 creator A5043928765 @default.
• W3201609182 creator A5046534303 @default.
• W3201609182 creator A5049680500 @default.
• W3201609182 creator A5056312424 @default.
• W3201609182 creator A5056694430 @default.
• W3201609182 creator A5057744043 @default.
• W3201609182 creator A5061112928 @default.
• W3201609182 creator A5072195410 @default.
• W3201609182 creator A5074151953 @default.
• W3201609182 creator A5089068328 @default.
• W3201609182 creator A5089694500 @default.
• W3201609182 creator A5089732639 @default.
• W3201609182 creator A5090008863 @default.
• W3201609182 date "2022-03-01" @default.
• W3201609182 modified "2023-10-11" @default.
• W3201609182 title "Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets" @default.
• W3201609182 cites W2065293650 @default.
• W3201609182 cites W2091037386 @default.
• W3201609182 cites W2107211326 @default.
• W3201609182 cites W2150575159 @default.
• W3201609182 cites W2165762354 @default.
• W3201609182 cites W2168133698 @default.
• W3201609182 cites W2611339248 @default.
• W3201609182 cites W2778123767 @default.
• W3201609182 cites W2790922923 @default.
• W3201609182 cites W2791118271 @default.
• W3201609182 cites W2803015076 @default.
• W3201609182 cites W2896105045 @default.
• W3201609182 cites W2899540665 @default.
• W3201609182 cites W2902173562 @default.
• W3201609182 cites W2905022043 @default.
• W3201609182 cites W2917357429 @default.
• W3201609182 cites W2945086019 @default.
• W3201609182 cites W2966632204 @default.
• W3201609182 cites W2968115401 @default.
• W3201609182 cites W2970756769 @default.
• W3201609182 cites W2972422665 @default.
• W3201609182 cites W3092144031 @default.
• W3201609182 cites W3126162611 @default.
• W3201609182 cites W4235642752 @default.
• W3201609182 doi "https://doi.org/10.1016/j.cllc.2021.09.002" @default.
• W3201609182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34645582" @default.
• W3201609182 hasPublicationYear "2022" @default.
• W3201609182 type Work @default.
• W3201609182 sameAs 3201609182 @default.
• W3201609182 citedByCount "8" @default.
• W3201609182 countsByYear W32016091822022 @default.
• W3201609182 countsByYear W32016091822023 @default.
• W3201609182 crossrefType "journal-article" @default.
• W3201609182 hasAuthorship W3201609182A5004501438 @default.
• W3201609182 hasAuthorship W3201609182A5013978940 @default.
• W3201609182 hasAuthorship W3201609182A5016050402 @default.
• W3201609182 hasAuthorship W3201609182A5020104705 @default.
• W3201609182 hasAuthorship W3201609182A5022092259 @default.
• W3201609182 hasAuthorship W3201609182A5032428632 @default.
• W3201609182 hasAuthorship W3201609182A5034124730 @default.
• W3201609182 hasAuthorship W3201609182A5043568223 @default.
• W3201609182 hasAuthorship W3201609182A5043928765 @default.
• W3201609182 hasAuthorship W3201609182A5046534303 @default.
• W3201609182 hasAuthorship W3201609182A5049680500 @default.
• W3201609182 hasAuthorship W3201609182A5056312424 @default.
• W3201609182 hasAuthorship W3201609182A5056694430 @default.
• W3201609182 hasAuthorship W3201609182A5057744043 @default.
• W3201609182 hasAuthorship W3201609182A5061112928 @default.
• W3201609182 hasAuthorship W3201609182A5072195410 @default.
• W3201609182 hasAuthorship W3201609182A5074151953 @default.
• W3201609182 hasAuthorship W3201609182A5089068328 @default.
• W3201609182 hasAuthorship W3201609182A5089694500 @default.
• W3201609182 hasAuthorship W3201609182A5089732639 @default.
• W3201609182 hasAuthorship W3201609182A5090008863 @default.
• W3201609182 hasConcept C121608353 @default.
• W3201609182 hasConcept C126322002 @default.
• W3201609182 hasConcept C142724271 @default.
• W3201609182 hasConcept C143998085 @default.
• W3201609182 hasConcept C160798450 @default.
• W3201609182 hasConcept C2775934546 @default.
• W3201609182 hasConcept C2776256026 @default.
• W3201609182 hasConcept C2779529041 @default.
• W3201609182 hasConcept C2779634585 @default.
• W3201609182 hasConcept C2781230642 @default.
• W3201609182 hasConcept C71924100 @default.
• W3201609182 hasConceptScore W3201609182C121608353 @default.
• W3201609182 hasConceptScore W3201609182C126322002 @default.
• W3201609182 hasConceptScore W3201609182C142724271 @default.
• W3201609182 hasConceptScore W3201609182C143998085 @default.
• W3201609182 hasConceptScore W3201609182C160798450 @default.
• W3201609182 hasConceptScore W3201609182C2775934546 @default.
• W3201609182 hasConceptScore W3201609182C2776256026 @default.

• next